3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Burkitt Lymphoma
1
Anus Neoplasms
1
Interventions
Oxaliplatin
29
Fluorouracil
23
Capecitabine
19
pembrolizumab
18
Nivolumab
17
Leucovorin
16
Docetaxel
10
Trastuzumab
9
Paclitaxel
9
Drug Therapy
9
Cisplatin
9
fludarabine
8
S 1 (combination)
8
Cyclophosphamide
8
Specimen Handling
7
trastuzumab deruxtecan
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
5
Biopsy
5
zolbetuximab
4
Irinotecan
4
Carboplatin
4
zimberelimab
3
sintilimab
3
olaparib
3
fludarabine phosphate
3
durvalumab
3
atezolizumab
3
aldesleukin
3
XELOX
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Diphenhydramine
×
90 days
×
Clear all
No trials found.